Sara A. McElheny, BA, is affiliated with Massachusetts General Hospital’s Ammon Pinizzotto Center for Women’s Mental Health and the Renaissance School of Medicine at Stony Brook University. Her publications in Psychiatrist.com focus on the reproductive safety and neonatal outcomes associated with second-generation atypical antipsychotics, particularly in the context of bipolar disorder among women. She has contributed to research analyzing data from the National Pregnancy Registry for Psychiatric Medications.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
